Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

  • This share is currently suspended. It was suspended at a price of 0.01
  • There is currently no data for VRS

Corporate Update

29 Jul 2025 07:00

RNS Number : 8890S
Versarien PLC
29 July 2025
 

 

 

29 July 2025

Versarien plc

("Versarien", the "Company" or the "Group")

Corporate Update

Versarien plc (AIM: VRS), the advanced engineering materials group, provides the following update on its restructuring process and financial position.

 

As stated in the Company's Interim Results, issued on 30 June 2025, the Board had appointed Leonard Curtis to undertake an accelerated sale of certain trade and assets of the Group's UK Technology companies (the "UK Technology Sale Process") whilst the Company focused on minimising the cash outflows from these operations. Other actions included seeking a strategic joint investment partner for the 3D Construction Printing ("3DCP") business and ceasing the trading activities of Versarien Korea Limited.

The UK Technology Sale Process has now concluded without a suitable offer being received by the Company. The Company therefore expects that Versarien Graphene Limited will shortly be placed into administration and Cambridge Graphene Limited and 2-DTech Limited will commence the process of voluntary liquidation. Versarien Korea Limited has now ceased all operations.

The ongoing Group will then consist of Versarien plc, Gnanomat SL and Total Carbide Limited (which the Company continues to market for sale) and will concentrate primarily on its hybrid nanomaterials and energy storage technologies.

These actions will conserve further cash and extend the Group's forecast runway through to the end of August 2025 to allow further time for the proposed, and previously announced, strategic investment to be closed, albeit there is no guarantee that it will do so. Should the strategic investment not be received the Board intends to appoint Leonard Curtis to conduct an accelerated sale process of the remaining Group assets.

Further announcements will be made in due course as appropriate.

For further information please contact:

 

Versarien

Stephen Hodge, Chief Executive Officer

Chris Leigh, Chief Financial Officer

 

c/o IFC

SP Angel Corporate Finance (Nominated Adviser and Broker)

Matthew Johnson, Adam Cowl

 

+44 (0)20 3470 0470

 

IFC Advisory Limited (Financial PR and Investor Relations)

Tim Metcalfe, Zach Cohen

+44 (0)20 3934 6630

 

For further information please see: http://www.versarien.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAEXPAAXSEAA
Date   Source Headline
4th Apr 20178:00 amRNSHolding(s) in Company
21st Mar 20177:00 amRNSCambridge Graphene Update
15th Mar 20179:43 amRNSHolding(s) in Company
9th Mar 20171:00 pmRNSHolding(s) in Company
6th Mar 20177:00 amRNSSuccessful Fundraising of £1.5 million
3rd Mar 20174:38 pmRNSFundraising of approximately £1 million
16th Feb 20177:00 amRNSNanene Distribution Agreement
8th Feb 20177:00 amRNSLaunch of Nanene
30th Jan 201710:04 amRNSHolding(s) in Company
19th Jan 20171:21 pmRNSAcquisition and Trading Update
19th Dec 20167:00 amRNSFurther Graphene Enhanced PAEK Plastics Agreement
14th Dec 201610:45 amRNSHolding(s) in Company
14th Dec 20167:00 amRNSGraphene enhanced PAEK Thermoplastics Agreement
29th Nov 20167:01 amRNSInterim Results
29th Nov 20167:00 amRNSSignificant Graphene Order
23rd Nov 20167:00 amRNSNotice of Results
9th Nov 201610:00 amRNSInvestor site visit presentations
31st Oct 20169:15 amRNSDebt for Equity Swap with UoM
27th Oct 20167:00 amRNSNew Healthcare Graphene Project
18th Oct 20167:00 amRNSInvestor Event
13th Oct 20167:00 amRNSCompletion of NGI composite project
3rd Oct 20167:00 amRNSAcquisition of AAC Cyroma
27th Sep 20161:38 pmRNSResult of AGM
1st Sep 201610:36 amRNSNotice of AGM
3rd Aug 20164:25 pmRNSHolding(s) in Company
2nd Aug 20169:53 amRNSHolding(s) in Company
1st Aug 20168:39 amRNSHolding(s) in Company
28th Jul 20162:01 pmRNSHolding(s) in Company
25th Jul 20167:00 amRNSFully subscribed placing to raise £1.1m
19th Jul 20167:00 amRNSFinal Results
23rd Jun 20167:00 amRNSGraphene Collaboration with CT Engineering
14th Jun 20167:00 amRNSGraphene Collaboration with Absolute Engineering
11th May 20167:00 amRNSGraphene enhanced carbon fibre collaboration
6th Apr 20167:00 amRNSTrading Update
31st Mar 20167:00 amRNS3D Printing with Graphene Trials
11th Mar 20167:00 amRNSResignation of Director
3rd Feb 20167:00 amRNSBoard Changes
11th Dec 20157:00 amRNSDirector Share Purchase
10th Dec 20157:00 amRNSInterim Results
1st Dec 20157:00 amRNSHolding(s) in Company
19th Nov 20157:00 amRNSNotice of Results
4th Nov 20157:00 amRNSChange of Adviser
12th Oct 201511:06 amRNSChange of Registered Office
24th Sep 201511:15 amRNSResult of AGM
21st Sep 20157:00 amRNSVersarien Attending SEC2SV in San Francisco
7th Sep 20157:00 amRNSGrant of US Graphene Patent
19th Aug 20159:53 amRNSAdditional Listing
18th Aug 20152:00 pmRNSPosting of Annual Report
21st Jul 20157:00 amRNSChange of Adviser
21st Jul 20157:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.